🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Zhongshan People's Hospital, Guangdong, China clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Zhongshan People's Hospital, Guangdong, China as lead sponsor. Synced 27 Sep 2026
6Current trials
6Recruiting now
0Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Zhongshan People's Hospital, Guangdong, China is the lead sponsor of 6 current clinical trials in our China register. 6 are recruiting patients now. The most common phase is Observational. The most-studied condition is Nasopharyngeal Carcinoma.

ClinicalTrials.gov trials by status

  • Recruiting6100%

Trials by phase

  • Observational350%
  • Not applicable350%
01

Clinical trials sponsored by Zhongshan People's Hospital, Guangdong, China

6 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Screening Effect of Dual-energy CT Combined With Nasopharyngeal Endoscopy for Screening Nasopharyngeal Carcinoma
NCT05884983 · ClinicalTrials.gov ↗ · Nasopharyngeal Carcinoma
Observational Recruiting 2023-02 China
Reducing High Risk Primary Tumor Clinical Target Volumes (CTVp1) in Non-metastatic Nasopharyngeal Carcinoma
NCT05994170 · ClinicalTrials.gov ↗ · Nasopharyngeal Carcinoma, Intensity-Modulated Radiotherapy
Not applicable Recruiting 2023-08 China
Head-to-Head Comparison of Hepatocellular Cancer (HCC) Screening Strategies: A Prospective Population-Based Cohort Study in Zhongshan City
NCT07010198 · ClinicalTrials.gov ↗ · Hepatocellular Cancer (HCC)
Observational Recruiting 2025-03 China
Xerostomia-optimised IMRT Versus Standard IMRT in NPC
NCT06282497 · ClinicalTrials.gov ↗ · Nasopharyngeal Carcinoma ,Xerostomia,Radiotherapy
Not applicable Recruiting 2023-10 China
Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer
NCT05990946 · ClinicalTrials.gov ↗ · Lung Neoplasms, Non-Small Cell Lung Cancer, Postoperative Complications, Patient Reported Outcome Measures
Not applicable Recruiting 2023-12 China
Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City
NCT04085900 · ClinicalTrials.gov ↗ · Nasopharyngeal Carcinoma
Observational Recruiting 2020-04 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Zhongshan People's Hospital, Guangdong, China trials

8 conditions
Nasopharyngeal Carcinoma3Intensity-Modulated Radiotherapy1Hepatocellular Cancer (HCC)1Nasopharyngeal Carcinoma ,Xerostomia,Radiotherapy1Lung Neoplasms, Non-Small Cell Lung Cancer1Postoperative Complications1Patient Reported Outcome Measures1Telerehabilitation1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in China66

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Nasopharyngeal Carcinoma

SponsorTrials
Sun Yat-sen University56
Zhejiang Cancer Hospital4
XIANG YANQUN3
Jiangxi Provincial Cancer Hospital3
Ming-Yuan Chen3
National Cancer Centre, Singapore3
Affiliated Cancer Hospital & Institute of Guangzhou Medical University1

Sponsors with the most current trials registered for this condition.

05

Questions about Zhongshan People's Hospital, Guangdong, China trials

How many clinical trials does Zhongshan People's Hospital, Guangdong, China sponsor?

Zhongshan People's Hospital, Guangdong, China is the lead sponsor of 6 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 27 September 2026. Completed and withdrawn studies are not counted.

Are Zhongshan People's Hospital, Guangdong, China trials recruiting?

Yes. 6 of its 6 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 27 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.